DiagnostiQ builds cartridge-based in-vitro diagnostic systems for hospital laboratories — a single analyser, six assay families and one result pipeline that hands a validated, LIS-ready answer to the ward in under twenty minutes.
Each panel ships as a room-temperature, sealed single-use cartridge with on-board controls — no reagent preparation, no cold chain, no open-tube handling between sample and result.
Rapid identification of the 26 most common bloodstream pathogens with direct mecA and vanA/vanB resistance calls from positive culture bottles.
Influenza A/B, RSV, SARS-CoV-2, hMPV and eighteen seasonal coronaviruses and adenoviruses in a single closed-tube amplification.
High-sensitivity troponin I for chest-pain pathways, with a 12-minute first result and serial sampling built into a single cartridge.
HbA1c, total cholesterol, HDL, LDL and triglycerides from one capillary or venous draw — built for diabetes and cardiovascular clinics.
Forty-eight autoantibody targets — ANA, ENA, anti-CCP, ANCA and coeliac serology — read in one multiplexed run from a single serum sample.
Twelve guideline-relevant somatic variants called from circulating tumour DNA in plasma, with a 0.05% variant allele detection floor.
Q-Core is our closed-cartridge platform: a lyse-and-capture front end, a six-channel fluorescence back end and a reporting layer that speaks the language your laboratory information system already understands.
The cartridge is seated in the dock and the sample is drawn in through a sealed microfluidic channel. Lysis, nucleic-acid capture and reagent rehydration all happen on-board, so nothing is pipetted by hand.
Thermal cycling runs in the cartridge while six fluorescence channels read each well in parallel. Signal processing flags inhibition, contamination and borderline calls before anything reaches a report.
Results are released to the analyst console and pushed into the hospital record the moment they are authorised — HL7 v2.5, ASTM and FHIR R4 interfaces ship in the box, not as an add-on licence.
Performance below comes from a nine-site method-comparison study run on prospective clinical samples, with sensitivity and specificity measured against a composite reference standard rather than against our own earlier kit.
Across 12,480 prospective samples, all nine sites pooled.
Composite reference standard, equivocal results excluded.
Specimen receipt to authorised result, routine daytime load.
220+ hospital and reference laboratories running Q-Core.
| Metric | DiagnostiQ Q-Core 200 | Reference method |
|---|---|---|
| Clinical sensitivity | 99.4% | 96.1% |
| Clinical specificity | 99.8% | 98.4% |
| Limit of detection | 12 copies/mL | 45 copies/mL |
| Median turnaround time | 17 min | 4.2 h |
| Operator hands-on time | 4 min | 38 min |
| Repeatability (CV) | 0.4% | 1.9% |
| Reportable genotypes / targets | 34 | 12 |
DiagnostiQ internal method-comparison study DX-1140 (n = 12,480 prospective clinical specimens; nine hospital sites; 2024–2025). Sensitivity and specificity are calculated against a composite reference standard of culture plus sequencing. Limit of detection determined by probit analysis at 95% detection probability. Figures describe the Q-Core 200 with current cartridge revisions and are provided for evaluation purposes only — they are not a guarantee of performance in any individual laboratory. Local validation against your own population remains the responsibility of the testing laboratory.
From single-site district hospitals to national reference networks, Q-Core installations are supported by DiagnostiQ field engineers and a validated training programme for laboratory staff.
We replaced a send-out pathway that took two days with a 17-minute in-house result. Sepsis escalation decisions at 3 a.m. are now made on a number, not on a hunch — that changed our antibiotic stewardship numbers measurably within two quarters.
Dr Daniel MwangiClinical Microbiology Lead, City General Hospital
The cartridge format is what sold the laboratory committee. No reagent prep, no cold chain, and the QC data lands in the audit trail without anyone typing it in. Revalidation after a cartridge revision was a morning's work, not a project.
Dr Wei-Lun ChenDirector of Laboratory Medicine, Westport University Hospital
Rolling Q-Core across six sites took eleven weeks including training. Their engineers were on-site for every go-live, and the HL7 interface to our record system worked on the first attempt — which, in my experience, is close to unheard of.
Sofia RennerChief Operating Officer, Northgate Health Trust
We appoint one exclusive distributor per territory and support them properly: demo units, technical training, regulatory dossiers and a co-funded launch. If you already sell to hospital laboratories, we would like to talk.
Tell us your territory and we will send the full distributor pack, assay menu and pricing schedule within two working days.
